| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |